🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06430554
Recruiting Observational

Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability

NCT06430554 · tracked via the Priya Life Science China tracker
Sponsor
Zhongda Hospital
Phase
Observational
Started
2024-06-08
Last updated
2026-09-03

Condition(s) studied

Respiratory Distress SyndromePositive-Pressure RespirationMechanical Ventilation

Study summary

This observational study will explore the effects of PEEP and position on regional lung ventilation-perfusion mismatch by electrical impedance tomography (EIT) in moderate-to-severe ARDS patients with different lung recruitability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. age ≥18 years 2. Moderate-to-severe ARDS as per the 2023 ESICM definition 3. Undergoing invasive mechanical ventilation 4. Planned prone position based on the attending physicians' decisions 5. Signed informed consent Exclusion Criteria: 1. age ≥85 years 2. Pregnancy 3. Severe hemodynamic instability (\> 30% increase in vasopressors in the last 6 hours or norepinephrine \> 0.5 µg/kg/min) 4. Clinically suspected elevated intracranial pressure (\>18 mm Hg) 5. Bronchopleural fistula 6. Contraindication to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode belt placement) 7. Severe hypernatremia (\>170mmol/L) 8. Re-admission of patients already enrolled in this study, or patients who are participating in other studies

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongda Hospital, Southeast University Nanjing Jiangsu Recruiting

More Zhongda Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06430554 on ClinicalTrials.gov ↗ ← All trials in China